Literature DB >> 24373767

NleH defines a new family of bacterial effector kinases.

Andrey M Grishin1, Maia Cherney2, Deborah H Anderson3, Sadhna Phanse4, Mohan Babu4, Miroslaw Cygler5.   

Abstract

Upon host cell infection, pathogenic Escherichia coli hijacks host cellular processes with the help of 20-60 secreted effector proteins that subvert cellular processes to create an environment conducive to bacterial survival. The NleH effector kinases manipulate the NF-κB pathway and prevent apoptosis. They show low sequence similarity to human regulatory kinases and contain two domains, the N-terminal, likely intrinsically unfolded, and a C-terminal kinase-like domain. We show that these effectors autophosphorylate on sites located predominantly in the N-terminal segment. The kinase domain displays a minimal kinase fold, but lacks an activation loop and the GHI subdomain. Nevertheless, all catalytically important residues are conserved. ATP binding proceeds with minimal structural rearrangements. The NleH structure is the first for the bacterial effector kinases family. NleHs and their homologous effector kinases form a new kinase family within the cluster of eukaryotic-like kinases that includes also Rio, Bud32, and KdoK families.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24373767     DOI: 10.1016/j.str.2013.11.006

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  11 in total

Review 1.  Structural insight into effector proteins of Gram-negative bacterial pathogens that modulate the phosphoproteome of their host.

Authors:  Andrey M Grishin; Ksenia A Beyrakhova; Miroslaw Cygler
Journal:  Protein Sci       Date:  2015-02-06       Impact factor: 6.725

2.  Quarterly intrinsic disorder digest (January-February-March, 2014).

Authors:  Shelly DeForte; Krishna D Reddy; Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2016-02-12

3.  Binding specificity of type three secretion system effector NleH2 to multi-cargo chaperone CesT and their phosphorylation.

Authors:  Manisha Yadav; Mahalashmi Srinivasan; Nikhil K Tulsian; Yu Xuan Liu; Qingsong Lin; Ilan Rosenshine; J Sivaraman
Journal:  Protein Sci       Date:  2021-12       Impact factor: 6.725

4.  Targeting of microvillus protein Eps8 by the NleH effector kinases from enteropathogenic E. coli.

Authors:  Georgina L Pollock; Andrey M Grishin; Cristina Giogha; Jiyao Gan; Clare V Oates; Paul J McMillan; Isabella Gaeta; Matthew J Tyska; Jaclyn S Pearson; Nichollas E Scott; Miroslaw Cygler; Elizabeth L Hartland
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-17       Impact factor: 12.779

Review 5.  Cooperative Immune Suppression by Escherichia coli and Shigella Effector Proteins.

Authors:  Maarten F de Jong; Neal M Alto
Journal:  Infect Immun       Date:  2018-03-22       Impact factor: 3.441

6.  A Bacterial Effector Mimics a Host HSP90 Client to Undermine Immunity.

Authors:  Victor A Lopez; Brenden C Park; Dominika Nowak; Anju Sreelatha; Patrycja Zembek; Jessie Fernandez; Kelly A Servage; Marcin Gradowski; Jacek Hennig; Diana R Tomchick; Krzysztof Pawłowski; Magdalena Krzymowska; Vincent S Tagliabracci
Journal:  Cell       Date:  2019-09-12       Impact factor: 41.582

7.  A systematic analysis of the RNA-targeting potential of secreted bacterial effector proteins.

Authors:  Caroline Tawk; Malvika Sharan; Ana Eulalio; Jörg Vogel
Journal:  Sci Rep       Date:  2017-08-24       Impact factor: 4.379

8.  Structural basis for arginine glycosylation of host substrates by bacterial effector proteins.

Authors:  Jun Bae Park; Young Hun Kim; Youngki Yoo; Juyeon Kim; Sung-Hoon Jun; Jin Won Cho; Samir El Qaidi; Samuel Walpole; Serena Monaco; Ana A García-García; Miaomiao Wu; Michael P Hays; Ramon Hurtado-Guerrero; Jesus Angulo; Philip R Hardwidge; Jeon-Soo Shin; Hyun-Soo Cho
Journal:  Nat Commun       Date:  2018-10-16       Impact factor: 14.919

9.  The structure of Legionella pneumophila LegK4 type four secretion system (T4SS) effector reveals a novel dimeric eukaryotic-like kinase.

Authors:  Ali Flayhan; Célia Bergé; Nathalie Baïlo; Patricia Doublet; Richard Bayliss; Laurent Terradot
Journal:  Sci Rep       Date:  2015-09-30       Impact factor: 4.379

10.  EPEC NleH1 is significantly more effective in reversing colitis and reducing mortality than NleH2 via differential effects on host signaling pathways.

Authors:  Sarah E Kralicek; Mai Nguyen; Ki-Jong Rhee; Rocio Tapia; Gail Hecht
Journal:  Lab Invest       Date:  2018-02-02       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.